
Dr A Velumani and his family will sell their 66.1 percent stake in Thyrocare to PharmEasy for Rs 4,546 crore. It?s a bumper value-unlocking for the family in the best year possible for the diagnostics business during the pandemic. The need for a change and de? Read More
reported by at Moneycontrol
Recent Comments